Vitiligo as durvalumab's immune-related adverse event in lung cancer

  1. Rogado, J.
  2. Buendía-Castaño, D.
  3. Alonso-García, S.R.
Aldizkaria:
Medicina Clinica

ISSN: 1578-8989 0025-7753

Argitalpen urtea: 2022

Alea: 158

Zenbakia: 7

Orrialdeak: 341-342

Mota: Artikulua

DOI: 10.1016/J.MEDCLI.2021.07.024 GOOGLE SCHOLAR